Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pierre Fabre Medicament represented by IRPF
Woman and Man Max 99 years
Pierre Fabre Medicament represented by IRPF
Update Il y a 5 ans
Prospective randomised clinical phase III trial of (alternating IV and oral) vinorelbine plus cisplatin versus docetaxel plus cisplatin in first line chemotherapy of locally advanced or metastatic non-small-cell lung cnacer patients
To compare time to Treatment Failure (TTF) for both regimens
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Pierre Fabre Medicament represented by IRPF
Update Il y a 5 ans
Phase II Study of Navelbine oral and Arimidex as neo-adjuvant treatment in post-menopausal women with locally advanced breast carcinoma
To assess the efficacy (by ultrasound) of oral vinorelbine and anastrozole combination in terms of down-staging (OR + stage).
Country
None
organs
None
Specialty
None
Closed trial
More information